PT Suparma Tbk (IDX:SPMA)
Indonesia · Delayed Price · Currency is IDR 150.00
+1.00 (0.67%)
Nov 5, 2026, 4:02 PM WIB
PT Suparma Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,950,010 | 2,740,742 | 2,729,636 | 2,658,521 | 3,138,054 | 2,794,453 | |
Revenue Growth | 6.97% | 0.41% | 2.67% | -15.28% | 12.30% | 29.88% |
Cost of Revenue | 2,493,540 | 2,313,902 | 2,324,167 | 2,196,750 | 2,427,849 | 2,212,061 |
Gross Profit | 456,470 | 426,840 | 405,469 | 461,771 | 710,205 | 582,392 |
Selling, General & Admin | 226,844 | 221,602 | 209,905 | 206,708 | 183,723 | 169,709 |
Other Operating Expenses | 5,759 | 7,336 | 5,228 | - | 613.51 | - |
Operating Expenses | 232,604 | 228,938 | 215,133 | 206,708 | 184,337 | 169,709 |
Operating Income | 223,866 | 197,902 | 190,336 | 255,063 | 525,868 | 412,683 |
Interest Expense | -46,628 | -39,978 | -35,208 | -34,876 | -32,682 | -31,355 |
Interest & Investment Income | 3,674 | 6,336 | 7,541 | 5,809 | 4,247 | 1,344 |
Currency Exchange Gain (Loss) | -58,981 | -23,929 | -29,452 | 9,086 | -65,997 | 335.94 |
Other Non Operating Income (Expenses) | -1,636 | -3,593 | -3,424 | 3,042 | 632.25 | 3,373 |
EBT Excluding Unusual Items | 120,295 | 136,737 | 129,793 | 238,124 | 432,068 | 386,381 |
Gain (Loss) on Sale of Investments | - | - | 4,650 | -461.94 | -622.47 | - |
Gain (Loss) on Sale of Assets | - | - | - | 186.72 | - | - |
Other Unusual Items | - | - | - | - | - | -8,871 |
Pretax Income | 120,295 | 136,737 | 134,443 | 237,849 | 431,446 | 377,510 |
Income Tax Expense | 19,120 | 30,507 | 29,604 | 59,190 | 95,308 | 83,184 |
Net Income | 101,175 | 106,231 | 104,839 | 178,658 | 336,138 | 294,326 |
Net Income to Common | 101,175 | 106,231 | 104,839 | 178,658 | 336,138 | 294,326 |
Net Income Growth | 73.26% | 1.33% | -41.32% | -46.85% | 14.21% | 81.10% |
Shares Outstanding (Basic) | 5,330 | 5,330 | 5,330 | 5,330 | 5,330 | 5,330 |
Shares Outstanding (Diluted) | 5,330 | 5,330 | 5,330 | 5,330 | 5,330 | 5,330 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 18.98 | 19.93 | 19.67 | 33.52 | 63.06 | 55.22 |
EPS (Diluted) | 18.98 | 19.93 | 19.67 | 33.52 | 63.06 | 55.22 |
EPS Growth | 73.26% | 1.33% | -41.32% | -46.85% | 14.21% | 81.10% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 514,429 | 542,722 | 671,488 | 654,950 | 862,153 | 744,770 |
Free Cash Flow Per Share | 96.51 | 101.82 | 125.97 | 122.87 | 161.74 | 139.72 |
Dividend Per Share | - | - | - | 7.101 | - | - |
Dividend Growth | - | - | - | 19.33% | - | - |
Gross Margin | 15.47% | 15.57% | 14.85% | 17.37% | 22.63% | 20.84% |
Operating Margin | 7.59% | 7.22% | 6.97% | 9.59% | 16.76% | 14.77% |
Profit Margin | 3.43% | 3.88% | 3.84% | 6.72% | 10.71% | 10.53% |
Free Cash Flow Margin | 17.44% | 19.80% | 24.60% | 24.64% | 27.47% | 26.65% |
EBITDA | 344,061 | 317,994 | 299,377 | 352,014 | 616,613 | 493,098 |
EBITDA Margin | 11.66% | 11.60% | 10.97% | 13.24% | 19.65% | 17.65% |
D&A For EBITDA | 120,195 | 120,092 | 109,041 | 96,951 | 90,745 | 80,415 |
EBIT | 223,866 | 197,902 | 190,336 | 255,063 | 525,868 | 412,683 |
EBIT Margin | 7.59% | 7.22% | 6.97% | 9.59% | 16.76% | 14.77% |
Effective Tax Rate | 15.89% | 22.31% | 22.02% | 24.89% | 22.09% | 22.04% |